Hemodynamic features of advanced cirrhosis due to chronic bile duct ligation

Journal of Nippon Medical School

Volumn 72, Issue 4, 2005, Pages 217-225

  Katsuta, Yasumi ^a   Zhang, Xue Jun ^a   Ohsuga, Masaru ^a   Akimoto, Toshio ^a   Komeichi, Hirokazu ^a   Shimizu, Shuji ^a   Inami, Toru ^a   Miyamoto, Akiko ^a   Satomura, Katsuaki ^a   Takano, Teruo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Anemia; Endothelin 1; Forward flow theory; Nitrate; Portal hypertension

Indexed keywords

ENDOTHELIN 1; NITRATE; NITRITE;

ANEMIA; ANIMAL MODEL; ARTERY BLOOD FLOW; ARTICLE; ATTENUATION; BILE DUCT LIGATION; BILIARY CIRRHOSIS; BRAIN BLOOD FLOW; CATHETER; CLINICAL FEATURE; COMMON BILE DUCT; CONSCIOUSNESS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMORAL ARTERY; HEMODYNAMICS; HEMOGLOBIN DETERMINATION; HEPATIC ARTERY; KIDNEY BLOOD FLOW; LIVER FUNCTION; LUNG BLOOD FLOW; MALE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD PRESSURE; RAT; RAT STRAIN; SPLANCHNIC BLOOD FLOW; SYSTEMIC CIRCULATION; TISSUE DISTRIBUTION;

ANIMALS; COMMON BILE DUCT; HEMODYNAMIC PROCESSES; HYPERTENSION, PORTAL; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 25144519612     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.72.217     Document Type: Article

References (33)

1. Lee SS, Girod C, Braillon A, Hadengue A, Lebrec D: Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium. Am J Physiol 1986; 251: G176-180.
2. Lee FY, Colombato LA, Albillos A, Groszmann RJ: Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats. Gastroenterology 1993; 105: 1464-1470.
3. Akimoto T, Hayashi N, Adachi M, Kobayashi N, Zhang XJ, Ohsuga M, Katsuta Y: Viability and plasma vitamin K levels in the common bile duct-ligated rats. Exp Anim 2005; 54: 155-161.
4. Sikuler E, Groszmann RJ: Interaction of flow and resistance in maintenance of portal hypertension in a rat model. Am J Physiol 1986; 250: G205-212.
5. Groszmann RJ, Vorobioff J, Riley E: Splanchnic hemodynamics in portal-hypertensive rats: measurement with gamma-labeled microspheres. Am J Physiol 1982; 242: G156-160.
6. Zhang XJ, Katsuta Y, Akimoto T, Ohsuga M, Aramaki T, Takano T: Intrapulmonary vascular dilatation and nitric oxide in hypoxemic rats with chronic bile duct ligation. J Hepatol 2003; 39: 724-730.
7. Sikuler E, Kravetz D, Groszmann RJ: Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol 1985; 248: G618-625.
8. Sikuler E, Groszmann RJ: Hemodynamic studies in long- and short-term portal hypertensive rats: the relation to systemic glucagon levels. Hepatology 1986; 6: 414-418.
9. Blanchet L, Lebrec D: Changes in splanchnic blood flow in portal hypertensive rats. Eur J Clin Invest 1982; 12: 327-330.
10. Premen AJ, Go VL, Banchs V, Benoit JN, Kvietys PR, Granger DN: Renal hyperemia in portal hypertension is not mediated by gastrointestinal peptides. Regul Pept 1986; 16: 39-49.
11. Kontos HA, Shapiro W, Mauck HP, Patterson JL Jr: General and regional circulatory alterations in cirrhosis of the liver. Am J Med 1964; 37: 526-535.
12. Gupta TK, Chen L, Groszmann RJ: Pathophysiology of portal hypertension. Clin Liver Dis 1997; 1: 1-12.
13. Gupta TK, Chen L, Groszmann RJ: Pathophysiology of portal hypertension. Baillieres Clin Gastroenterol 1997; 11: 203-219.
14. Bosch J, Pizcueta P, Feu F, Fernandez M, Garcia-Pagan JC: Pathophysiology of portal hypertension. Gastroenterol Clin North Am 1992; 21: 1-14.
15. Tsai YT, Lin HC, Lee SD: Recent advances in the Pathophysiology of portal hypertension. J Gastroenterol Hepatol 1997; 12: S283-287.
16. Mo Vorobioff J, Bredfeldt JE, Groszmann RJ: Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol 1983; 244: G52-57.
17. Benoit JN, Womack WA, Hernandez L, Granger DN: "Forward" and "backward" flow mechanisms of portal hypertension. Relative contributions in the rat model of portal vein stenosis. Gastroenterology 1985; 89: 1092-1096.
18. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR: Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
19. Ando K, Hirata Y, Shichiri M, Emori T, Marumo F: Presence of immunoreactive endothelin in human plasma. FEBS Lett 1989; 245: 164-166.
20. Komeichi H, Katsuta Y, Aramaki T, Okumura H: A new experimental animal model of portal hypertension. Intrahepatic portal obstruction by injecting DEAE-cross-linked dextran microspheres into the portal vein in the rabbit. Nippon Ika Daigaku Zasshi 1991; 58: 273-284.
21. Yang YY, Lin HC, Lee WC, Huang YT, Hou MC, Lee FY, Chang FY, Lee SD: Plasma erythropoietin level in patients with cirrhosis and its relationship to the severity of cirrhosis and renal function. J Gastroenterol Hepatol 2003; 18: 1156-1161.
22. Cirera I, Elizalde JI, Pique JM, Feu F, Casadevall M, Goldin E, Teres J, Bosch J, Rodes J: Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension. Dig Dis Sci 1997; 42: 1697-1702.
23. Luo B, Abrams GA, Fallon MB: Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction. J Hepatol 1998; 29: 571-578.
24. Zhang M, Luo B, Chen SJ, Abrams GA, Fallon MB: Endothelin-1 stimulation of endothelial nitric oxide synthase in the pathogenesis of hepatopulmonary syndrome. Am J Physiol 1999; 277 (5 Pt 1): G944-952.
25. Casadevall M, Pique JM, Cirera I, Goldin E, Elizalde I, Panes J, Martinez-Cuesta MA, Bosch J, Teres J, Rodes J: Increased blood hemoglobin attenuates splanchnic vasodilation in portal-hypertensive rats by nitric oxide inactivation. Gastroenterology 1996; 110: 1156-1165.
26. Gines P, Guevara M, Arroyo V, Rodes J: Hepatorenal syndrome. Lancet 2003; 362: 1819-1827.
27. Gines P, Fernandez-Esparrach G, Arroyo V, Rodes J: Pathogenesis of ascites in cirrhosis. Semin Liver Dis 1997; 17: 175-189.
28. Epstein M, Berk DP, Hollenberg NK, Adams DF, Chalmers TC, Abrams HL, Merrill JP: Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med 1970; 49: 175-185.
29. Sacerdoti D, Merlo A, Merkel C, Zuin R, Gatta A: Redistribution of renal blood flow in patients with liver cirrhosis. The role of renal PGE2. J Hepatol 1986; 2: 253-261.
30. Fernandez-Munoz D, Caramelo C, Santos JC, Blanchart A, Hernando L, Lopez-Novoa JM: Systemic and splanchnic hemodynamic disturbances in conscious rats with experimental liver cirrhosis without ascites. Am J Physiol 1985; 249: G316-320.
31. Cardenas A: Hepatorenal syndrome: a dreaded complication of end-stage liver disease. Am J Gastroenterol 2005; 100: 460-467.
32. Moreau R: Hepatorenal syndrome in patients with cirrhosis. J Gastroenterol Hepatol 2002; 17: 739-747.
33. Wong F, Blendis L: New challenge of hepatorenal syndrome: prevention and treatment. Hepatology 2001; 34: 1242-1251.